Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited (ARISTO): company summary
The company's business has improved, with annual revenue rising 14.4% and net profit growing 79.5% year-over-year.
Aristo Bio-Tech And Lifescience Limited (ARISTO) is a micro-cap Chemicals company valued at ₹61 crore operating in Pesticides & Agrochemicals on the NSE and BSE.
- Recent price move
- Aristo Bio-Tech And Lifescience Limited last traded at ₹89.3, sharply down 5.00% on the day.
- Financial performance
- The company's business has improved, with annual revenue rising 14.4% and net profit growing 79.5% year-over-year. The latest quarter showed revenue up 2.9% compared to the same quarter a year earlier, while net profit remained flat at ₹3 crore.
- Valuation multiples
- The stock trades at 8.5 times earnings, 1.65 times book value. It yields 0.5%.
- Things to watch
- The stock is 32.4% below its 52-week high, and the company's net profit margin, though up, remains low at 2.0%. The company's revenue growth has slowed in the latest quarter compared to the strong performance in the previous quarter.
- Where it stands
- Aristo Bio-Tech and Lifescience Ltd has shown strong growth in both revenue and net profit over the past year, with a net profit margin that has improved. The stock is currently trading below its 52-week high, and the latest quarter's revenue growth was modest compared to the prior quarter.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.2) and valuation (8.2), but held back by momentum (1.4). Growth looks strong at 9.2, but that is offset by momentum at 1.4. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 48% a year
- Profitable in all of the last 5 years
- Undemanding at 8× earnings
- Momentum is weak (1.4/10)
- Near the bottom of its 52-week range (25%)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Pesticides & Agrochemicals
Explore Aristo Bio-Tech And Lifescience Limited’s valuation
Free deep-dive tools · no sign-up
Aristo Bio-Tech And Lifescience Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Aristo Bio-Tech And Lifescience Limited with the ratios and calculators DocStoX uses in its analysis.

